相关实验视频

Updated: Jul 14, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

脂肪酸结合蛋白5调节了对抗税性前列腺癌细胞中的多塞素敏感性

Andrew Hillowe¹, Chris Gordon¹, Liqun Wang¹

¹Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.

|October 5, 2023

概括

脂肪酸结合蛋白5 (FABP5) 通过降低P-糖蛋白 (ABCB1) 表达,使得抗税的前列腺癌细胞对多塞素敏感. 这揭示了FABP5在克服化疗耐药性的新作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

前列腺癌是男性癌症死亡的主要原因之一.
晚期前列腺癌往往会变得耐和转移性.
像多塞塔克塞尔一样,TAXAN化学疗法是主要的治疗方法,但耐药性很常见.
脂肪酸结合蛋白5 (FABP5) 在晚期前列腺癌中受到上调,并推动癌症的进展.

研究的目的:

调查FABP5在前列腺癌中对高素抗性的作用.
为了确定FABP5是否调节dcetaxel敏感性和耐药性机制.

主要方法:

使用了抗分类素的DU145-TXR和对分类素敏感的DU145细胞.
进行了细胞毒性,细胞亡和细胞循环检测.
评估了FABP5敲击对多塞塔克塞尔反应的影响.
分析了P-糖蛋白 (ABCB1) 的表达和活性.

主要成果:

通过FABP5的敲除,对对多塞塔克塞尔的抗分抗性DU145-TXR细胞产生了敏感性.
FABP5倒置并没有影响对税敏感的DU145细胞中的多塞塔克塞尔强度.
在DU145-TXR细胞中,分抗性与ABCB1上调有关.
抑制FABP5显著降低了抗性细胞中的ABCB1表达和活性.

结论:

在前列腺癌中,FABP5在调解高抗性方面发挥着至关重要的作用.
准FABP5可能是克服多塞素耐药性的策略.
FABP5调节了P-糖蛋白排泄ABCB1.1.的表达和活性.

更多相关视频

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Tissue-Drug Binding: Localization of Drugs and its Significance

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...